Episode Details

Back to Episodes
Infectious Disease, Epidemiology, Pandemics, Health Policy, Big Science, Politicization of Science | Jay Bhattacharya | 100

Infectious Disease, Epidemiology, Pandemics, Health Policy, Big Science, Politicization of Science | Jay Bhattacharya | 100

Season 2 Episode 100 Published 3 years ago
Description

Send us a text

Nick talks to Jay Bhattacharya, MD, PhD, who is a professor of medicine & economics at Stanford University. They discuss various aspects of the COVID pandemic, such as: how infectious, transmissible, and deadly SARS-CoV-2 is; mRNA vaccines, how well they stop transmission vs. severe COVID, and whether they can induce negative side effects such as myocarditis; how well masks really work; Jay's inclusion in the "TwitterFiles" and the suppression of speech on social media; what he thinks of Elon Musk after meeting him; his thoughts on the future of public health governance in the US.

Related episodes:

  • M&M #61: Public Health, Pandemics, Epidemiology, SARS-CoV-2 & COVID Public Policy | Martin Kulldorff

*This content is never meant to serve as medical advice

Support the show

Health Products by M&M Partners:

  • SporesMD: Premium mushrooms products (gourmet mushrooms, nootropics, research). Use code TRIKOMES for 20% off.
  • Lumen device: Optimize your metabolism for weight loss or athletic performance. MINDMATTER gets you 15% off.
  • AquaTru: Water filtration devices that remove microplastics, metals, bacteria, and more from your drinking water. Through link, $100 off AquaTru Carafe, Classic & Under Sink Units; $300 off Freestanding models.
  • Seed Oil Scout: Find restaurants with seed oil-free options, scan food products to see what they’re hiding, with this easy-to-use mobile app.
  • KetoCitra—Ketone body BHB + electrolytes formulated for kidney health. Use code MIND20 for 20% off any subscription (cancel anytime)

For all the ways you can support my efforts


Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us